Cash for CA stem cell co's

Six California stem cell biotech companies received more than $5 million in funding last week from the state's stem cell funding body -- the California Institute for Regenerative Medicine (CIRM), according to a linkurl:news release ;http://www.cirm.ca.gov/pdf/ICOC_121008.pdf from the agency. The money represents the first major pay out to companies from the state's $3 billion research enterprise. Until now, only Novocell Inc. had received a small grant of $50,000. The grants are part of 23 gr

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Six California stem cell biotech companies received more than $5 million in funding last week from the state's stem cell funding body -- the California Institute for Regenerative Medicine (CIRM), according to a linkurl:news release ;http://www.cirm.ca.gov/pdf/ICOC_121008.pdf from the agency. The money represents the first major pay out to companies from the state's $3 billion research enterprise. Until now, only Novocell Inc. had received a small grant of $50,000. The grants are part of 23 grants and nearly $20 million awarded to California institutions for the development of tools and technologies to overcome barriers in stem cell research. Three companies who weren't awarded money filed petitions last week as the
working group was finalizing its granting decisions, complaining that the grant allocations were biased toward academic institutions. CIRM
President Alan Trounson, however, said he could not find "compelling evidence" to change the score of any of the applications, or the decision of the CIRM working group that allocates the funding, according to linkurl:The California Stem Cell Report;.http://californiastemcellreport.blogspot.com/
 The companies who won the grants are Novocell, VistaGen Therapeutics, Fluidigm Corp., Gamma-Medica Ideas, Novocell Inc., Invitrogen, and Vala Sciences.
**__Related stories:__***linkurl:Calif. stem cell agency back on track?;http://www.the-scientist.com/news/display/53676/
[4 October 2007]*linkurl:CIRM cuts ten grants;http://www.the-scientist.com/blog/display/53978/
[7 December 2007]*linkurl:CIRM to pay for eggs?;http://www.the-scientist.com/blog/display/54506/
[27 March 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Andrea Gawrylewski

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide